Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00013886
DRKS00013886
Completed
Not Applicable

Prospective, controlled pilot study for the use of non-contact perfusion and thermography measurements in patients with peripheral arterial disease, chronic venous insufficiency, or diabetes mellitus (with or without ulceration) compared to patients with spider vein varikosis

Phlebologisches Studienzentrum am Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken0 sites37 target enrollmentJanuary 30, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCirculatory disorders in venous disease, arterial occlusive disease and diabetes mellitus in cf. to spider veins varicosisI87I70.2E13I83.9Other disorders of veinsAtherosclerosis of arteries of extremitiesOther specified diabetes mellitusVaricose veins of lower extremities without ulcer or inflammation

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Circulatory disorders in venous disease, arterial occlusive disease and diabetes mellitus in cf. to spider veins varicosis
Sponsor
Phlebologisches Studienzentrum am Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken
Enrollment
37
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 30, 2018
End Date
February 26, 2018
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Phlebologisches Studienzentrum am Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken

Eligibility Criteria

Inclusion Criteria

  • •Men and women
  • •Age\> 18 years
  • •written consent
  • •Possibility and will to participate
  • •Known vascular disease of the legs in defined stages (CVI C3\-C6 or PAD
  • •IIb\-IV or diabetes mellitus with / without ulceration) or healthy leg vessels (spider veins / ret. Varices only)
  • •No surgical or interventional treatment of the legs / leg vessels in the last 6 months

Exclusion Criteria

  • •Lack of consent
  • •Lack of will or lack of opportunity to follow the examination protocol
  • •Acute thrombosis of the arterial or venous leg vessels
  • •Acute inflammation of the legs
  • •Extensive scars on the legs after trauma
  • •immobilization
  • •Pregnancy, breastfeeding
  • •Skin type IV to VI

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A randomised controlled pilot study in the use of hyperbaric oxygen therapy versus metronidazole in chronic pouchitisPouchitisDigestive SystemUlcerative colitis
ISRCTN83399182Department of Health (UK)30
Active, not recruiting
Phase 1
se of Cetrotide as a medication in Frozen Embryo Replacement IVF cycles
EUCTR2018-001915-63-GBniversity of Oxford / Clinical Trials and Research Governance300
Recruiting
Not Applicable
itric oxide donors drugs for treatment of recurrent abortion due to primary antiphospholipid syndromerecurrent abortionprimary antiphospholipid syndromeReproductive Health and Childbirth - AbortionInflammatory and Immune System - Autoimmune diseases
ACTRN12613001085763Benha university hospital34
Completed
Not Applicable
Safety and efficacy of Transcend CyPass glaucoma implant in open angle glaucoma patients who have failed medical treatmentPrimary open angle glaucomaEye DiseasesGlaucoma
ISRCTN23263504Transcend Medical, Inc.™ (USA)20
Completed
Not Applicable
Transcend CyPass glaucoma implant and cataract surgery in open angle glaucoma patients
ISRCTN86839890Transcend Medical, Inc.™ (USA)20